kras g12c genetic testing is a molecular diagnostic test used to detect specific gene mutations in the KRAS gene, which is commonly mutated in several types of cancer, including non-small cell lung cancer (NSCLC). these mutations can aid in the diagnosis, prognosis, and treatment planning of patients with NSCLC.
The testing is performed using a variety of techniques, including polymerase chain reaction (PCR), next-generation sequencing (NGS), and droplet digital polymerase chain reaction (ddPCR). these methods allow for the accurate detection of various KRAS mutations, including those that may not have been previously identified.
In recent years, the adoption of genetic testing for NSCLC has increased significantly, as advancements in technology have made it more accessible and affordable. Additionally, the availability of targeted therapies and other treatments personalized to specific genetic mutations have highlighted the importance of identifying these mutations promptly.
One area where kras g12c genetic testing is particularly important is in the development of targeted therapies for patients with KRAS-mutated NSCLC. These靶向 therapies, which are designed to specifically target the mutatedKRAS gene or its downstream pathways, have shown promising results in clinical trials and are being studied in ongoing clinical trials.
